| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/26/2003 | EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators |
| 02/26/2003 | EP1285063A1 Anti-angiogenic polypeptides |
| 02/26/2003 | EP1284963A1 Novel calcium receptor active molecules and method for preparing same |
| 02/26/2003 | EP1284958A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 02/26/2003 | EP1284753A2 Combination of growth hormone secretagogues and antidepressants |
| 02/26/2003 | EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 02/26/2003 | EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 02/26/2003 | EP1284721A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399633A 嘧啶衍生物 Pyrimidine derivatives |
| 02/26/2003 | CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/26/2003 | CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/26/2003 | CN1399557A Remedies for drug-resistant hypercalcemia |
| 02/26/2003 | CN1399533A Improved transdermal contraceptive delivery system and process |
| 02/26/2003 | CN1398620A Capsule made of hairyvein agrimonia herb, the dried rhizome of rehmannia and Chinese angelica |
| 02/26/2003 | CN1398582A Local acne treating device |
| 02/26/2003 | CN1102144C Noval pyrimidine derivatives and prepn. processes thereof |
| 02/25/2003 | US6525196 5HT1 antagonists for antidepressant therapy |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525067 Substituted heterocyclic derivatives |
| 02/25/2003 | US6525056 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders |
| 02/25/2003 | US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine; |
| 02/25/2003 | US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 02/25/2003 | US6524580 Method for treating thyroid disorders |
| 02/22/2003 | CA2355573A1 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
| 02/20/2003 | WO2003014318A2 Methods for treating diabetes and other blood sugar disorders |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014158A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 02/20/2003 | WO2003014141A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 02/20/2003 | WO2003014083A1 Spiro compounds |
| 02/20/2003 | WO2003013573A1 Polypeptide conjugates with extended circulating half-lives |
| 02/20/2003 | WO2003013549A2 Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals |
| 02/20/2003 | WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | WO2003013509A1 N-phenylpyrrole guanidine derivatives as melanocortin reception ligands |
| 02/20/2003 | WO2003013485A1 Inhibitors of hb-egf (erbb) receptors for treating myeloma |
| 02/20/2003 | WO2003013475A1 Injectable foam and novel pharmaceutical applications thereof |
| 02/20/2003 | WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace |
| 02/20/2003 | WO2002096927A3 Ribozyme based treatment of female reproductive diseases |
| 02/20/2003 | WO2002085375A8 Novel hormone composition |
| 02/20/2003 | WO2002053090A3 Medicinal association of a biguanine (metformin) and arginine |
| 02/20/2003 | WO2002029088A9 Highly expressible genes |
| 02/20/2003 | WO2002008268A3 Leucine-based motif and clostridial neurotoxins |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | US20030036512 A neurotrophic factor, such as brain-derived neurotrophic factor; treating leptin resistance caused hypertension, sterility, obesity, glucose metabolic abnormality, ischemic disease and growth hormone insufficiency |
| 02/20/2003 | US20030035794 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 02/20/2003 | CA2459071A1 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma |
| 02/20/2003 | CA2456881A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 02/20/2003 | CA2456599A1 Spiro compounds |
| 02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/19/2003 | EP1284273A2 Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them |
| 02/19/2003 | EP1284272A1 Estra-1,3,5(10)-triene derivatives |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283834A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283833A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283832A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283828A1 Novel polymorph v of torasemide |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283735A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 02/19/2003 | EP1283700A2 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 02/19/2003 | EP1131327B1 Prostaglandin conjugates for treating or preventing bone diseases |
| 02/19/2003 | EP0920429B1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 02/19/2003 | CN1398186A Pharmaceutical compsn. comprising pectin effective in inhibiting male productive toxxicity |
| 02/19/2003 | CN1397271A Process for preparing medicine applying system in cavity or duct |
| 02/19/2003 | CN1101685C Making method of snail health products |
| 02/18/2003 | US6521657 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
| 02/18/2003 | US6521644 Compositions for promoting growth |
| 02/18/2003 | US6521643 Pyridine compounds and their pharmaceutical use |
| 02/18/2003 | CA2351004C Formulation |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012139A2 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003011855A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | WO2003011841A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 02/13/2003 | WO2003011839A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| 02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | WO2003011301A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 02/13/2003 | WO2003011293A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011285A1 BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES |
| 02/13/2003 | WO2003011282A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2002094275A8 Use of estrogen compounds to increase libido in women |
| 02/13/2003 | WO2002087546A3 Method for manufacturing a low dose pharmaceutical composition |
| 02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2002007758A3 Method for induced lactation |
| 02/13/2003 | WO2001087286A3 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 02/13/2003 | WO2001085763A3 Chimeric peptide immunogens their preparation and use |
| 02/13/2003 | US20030032656 2-Amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 02/13/2003 | US20030032594 Intracellular delivery of biological effectors |
| 02/13/2003 | US20030032588 Glucagon antagonists |
| 02/13/2003 | US20030032179 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2456192A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof |